Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer
This article is from
The Cancer Letter
archive.
Vol. 33 No. 1 | January 29, 2010
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.
May 4, 2001
TCL Archive
DCIS With Higher Density May Increase Risk For Disease
October 29, 2010
TCL Archive
FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled
November 28, 1975
TCL Archive
ONS Calls For Changes To Resolve Nurse Shortage
June 8, 2001
TCL Archive
More Oncopathology Research Asked
June 30, 1978
TCL Archive
Letter to The Editor: IOM Panel Urges Greater Integration Of Research
February 12, 1999